Edition:
India

Healios KK (4593.T)

4593.T on Tokyo Stock Exchange

1,608JPY
20 Jun 2018
Change (% chg)

¥-53 (-3.19%)
Prev Close
¥1,661
Open
¥1,660
Day's High
¥1,660
Day's Low
¥1,566
Volume
148,200
Avg. Vol
117,418
52-wk High
¥2,229
52-wk Low
¥1,345

Latest Key Developments (Source: Significant Developments)

Healios KK to set up unit Organoid Neogenesis Laboratory
Tuesday, 29 May 2018 

May 29(Reuters) - Healios KK <4593.T>:Says it will set up a subsidiary Organoid Neogenesis Laboratory Inc., which will be mainly engaged in research and development of pharmaceuticals, in Tokyo, in June .  Full Article

Healios KK and NEI enter into collaborative research and development agreement
Thursday, 24 May 2018 

May 24(Reuters) - Healios KK <4593.T>:Says the company has executed the collaborative research and development agreement with the National Eye Institute (NEI).The scope of this collaboration is the development of an allogeneic induced pluripotent stem cell (iPSC)-derived retinal pigment epithelium (RPE) cell therapy for age-related macular degeneration.  Full Article

Healios says exercise of options
Monday, 20 Nov 2017 

Nov 20 (Reuters) - Healios KK <4593.T>:Says 8,000 units of its 10th series options were exercised to 800,000 shares of its common stock from Nov. 1 to Nov. 20.Says 3,000 units of its 10th series options were exercised to 300,000 shares of its common stock on Nov. 2, at the price of 1,314 yen per share.Says 5,000 units of its 10th series options were exercised to 500,000 shares of its common stock on Nov. 20, at the price of 1,304 yen per share.  Full Article

Healios says First Patient is enrolled in clinical trial of adult stem cell regenerative medicine HLCM051 in patients with ischemic stroke in Japan
Wednesday, 15 Nov 2017 

Nov 15 (Reuters) - Healios KK <4593.T>:Says it announces that the first patient has been enrolled and treated in a clinical trial of adult stem cell regenerative medicine HLCM051 in patients with acute ischemic stroke in Japan, named TREASURE study .  Full Article

Healios announces exercise of options
Monday, 30 Oct 2017 

Oct 30(Reuters) - Healios KK <4593.T>:Says 12,000 units of its tenth series options were exercised to 1.2 million shares of its common stock from Oct. 2 to Oct. 30.  Full Article

BRIEF-Healios to set up U.S.-based unit Healios N.A.

* Says it will set up a wholly owned unit Healios N.A. Inc, which will be engaged in development of medical supplies in March